MedTrace Logo

PIONIR Study (Presillion™ and Presillion™ Plus Stent Systems)

NCT00840775 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 278

Last updated 2018-03-27

No results posted yet for this study

Summary

The purpose of this study is to collect and analyze additional information about the safety and effectiveness of the Presillion™ Stent System in the treatment of de novo stenotic lesions in native coronary arteries.

Conditions

  • Ischemic Heart Disease

Interventions

DEVICE

Catheterization, stent deployment

Standard catheterization procedure including Bare Metal Stent deployment.

Sponsors & Collaborators

  • Medinol Ltd.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-04-30
Primary Completion
2011-01-31
Completion
2011-06-30

Countries

  • Belgium
  • Germany
  • Israel
  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00840775 on ClinicalTrials.gov